68Ga-FAPI-46
IC 2022-02
Phase 2 small_molecule active
Quick answer
68Ga-FAPI-46 for Triple-negative breast cancer (TNBC) patients at high risk of relapse is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Triple-negative breast cancer (TNBC) patients at high risk of relapse
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active